Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$8.39
-1.1%
$8.59
$7.11
$11.90
$1.14B1.641.31 million shs4.10 million shs
Heska Co. stock logo
HSKA
Heska
$119.99
$119.09
$57.83
$120.03
$1.31B1.58241,932 shsN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$2.04
-3.3%
$2.42
$2.03
$5.20
$224.54M1.27612,170 shs655,478 shs
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$234.68
-2.3%
$227.41
$178.26
$366.41
$1.85B1.12106,042 shs111,405 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
-1.06%-2.44%-7.40%-16.02%-25.36%
Heska Co. stock logo
HSKA
Heska
0.00%0.00%0.00%0.00%0.00%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-3.32%-7.27%-7.27%-33.98%-53.74%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
-2.32%+0.73%+2.39%+18.02%-7.53%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.8494 of 5 stars
3.51.00.00.03.11.73.8
Heska Co. stock logo
HSKA
Heska
N/AN/AN/AN/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.1072 of 5 stars
3.55.00.00.00.01.70.6
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.5774 of 5 stars
1.31.00.00.02.62.50.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
3.00
Buy$13.4059.71% Upside
Heska Co. stock logo
HSKA
Heska
0.00
N/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.00
Buy$7.50267.65% Upside
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
2.50
Moderate Buy$252.007.38% Upside

Current Analyst Ratings Breakdown

Latest AHCO, UFPT, HSKA, and MXCT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/12/2025
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $13.00
5/8/2025
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$14.00 ➝ $13.00
5/7/2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetBuy ➝ Buy$252.00
3/28/2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
Raymond James Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageMarket Perform
(Data available from 6/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$3.26B0.35$3.75 per share2.24$11.72 per share0.72
Heska Co. stock logo
HSKA
Heska
$257.31M5.09$1.69 per share70.99$39.00 per share3.08
MaxCyte, Inc. stock logo
MXCT
MaxCyte
$38.63M5.62N/AN/A$1.95 per share1.05
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$547.56M3.30$10.47 per share22.41$44.66 per share5.25
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
$90.42M$0.5714.728.650.982.63%6.96%2.40%8/5/2025 (Estimated)
Heska Co. stock logo
HSKA
Heska
-$19.89M-$1.93N/A83.33N/A-7.86%0.94%0.67%N/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$41.06M-$0.40N/AN/AN/A-110.92%-19.90%-17.24%8/5/2025 (Estimated)
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$58.98M$8.1728.72N/A11.59%21.27%12.24%7/30/2025 (Estimated)

Latest AHCO, UFPT, HSKA, and MXCT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
MaxCyte, Inc. stock logo
MXCT
MaxCyte
-$0.10-$0.10N/A-$0.10$9.05 million$10.39 million
5/6/2025Q1 2025
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
$2.05$2.47+$0.42$2.21$139.93 million$148.15 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
N/AN/AN/AN/AN/A
Heska Co. stock logo
HSKA
Heska
N/AN/AN/AN/AN/A
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/AN/AN/AN/AN/A
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.25
1.29
1.07
Heska Co. stock logo
HSKA
Heska
0.23
5.64
4.12
MaxCyte, Inc. stock logo
MXCT
MaxCyte
N/A
12.23
11.58
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
0.47
2.58
1.45

Institutional Ownership

CompanyInstitutional Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
82.67%
Heska Co. stock logo
HSKA
Heska
99.01%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
68.81%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
87.28%

Insider Ownership

CompanyInsider Ownership
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
1.55%
Heska Co. stock logo
HSKA
Heska
12.30%
MaxCyte, Inc. stock logo
MXCT
MaxCyte
3.30%
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
4.40%
CompanyEmployeesShares OutstandingFree FloatOptionable
AdaptHealth Corp. stock logo
AHCO
AdaptHealth
10,500134.95 million132.86 millionOptionable
Heska Co. stock logo
HSKA
Heska
80810.91 million9.57 millionNot Optionable
MaxCyte, Inc. stock logo
MXCT
MaxCyte
80106.42 million102.90 millionOptionable
UFP Technologies, Inc. stock logo
UFPT
UFP Technologies
4,3357.71 million7.37 millionOptionable

Recent News About These Companies

What Makes UFP Technologies (UFPT) a Prospective Bet?

New MarketBeat Followers Over Time

Media Sentiment Over Time

AdaptHealth stock logo

AdaptHealth NASDAQ:AHCO

$8.39 -0.09 (-1.06%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$8.49 +0.10 (+1.25%)
As of 06/20/2025 06:47 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also offers wheelchairs, hospital beds, oxygen concentrators, CPAP masks and related supplies, wound care supplies, diabetes management supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. The company is headquartered in Plymouth Meeting, Pennsylvania.

Heska stock logo

Heska NASDAQ:HSKA

Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia. The company offers Element DC, Element DCX, Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element RC, Element RCX, and Element RC3X chemistry systems for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus veterinary hematology analyzers to measure blood cell, platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; and Element COAG and Element AIM veterinary analyzers. It also provides HeskaView Telecytology that provides in-clinic automated microscopic slide scanning and computing equipment; IV infusion pumps; digital radiography hardware and mobile digital radiography products; ultrasound systems; Cloudbank, a Web-based image storage solution; point-of-care products to detect antigens and antibodies associated with infectious and parasitic diseases of animals; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels and therapy shots or drops. In addition, the company provides a line of bovine vaccines; biological and pharmaceutical products to other animal health companies; turnkey services comprising research, licensing, production, labeling, and packaging; and validation support and distribution services. It sells its products to veterinarians through a telephone sales force and third-party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. The company was incorporated in 1988 and is based in Loveland, Colorado.

MaxCyte stock logo

MaxCyte NASDAQ:MXCT

$2.04 -0.07 (-3.32%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$2.04 0.00 (-0.25%)
As of 06/20/2025 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MaxCyte, Inc., a life sciences company, discovers, develops, and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expression of therapeutic targets for cell-based assays; ExPERT GTx, a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs, such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies, as well as to pharmaceutical and biotechnology companies for use in drug discovery and development, and bio-manufacturing. MaxCyte, Inc. was incorporated in 1998 and is headquartered in Rockville, Maryland.

UFP Technologies stock logo

UFP Technologies NASDAQ:UFPT

$234.68 -5.57 (-2.32%)
Closing price 06/20/2025 04:00 PM Eastern
Extended Trading
$234.50 -0.18 (-0.07%)
As of 06/20/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

UFP Technologies, Inc. designs and manufactures solutions for medical devices, sterile packaging, and other highly engineered custom products. The company offers protective drapes for robotic surgery, single patient use surfaces, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, biopharma drug manufacturing, and coils for catheters; and molded components for applications in acoustic insulation, interior trim, load floors, sunshades, SUV cargo cover handles, driveshaft damping, engine and manifold covers, quarter panels, and wheel liners. It also provides molded composites for commercial aviation and military gear for use in backpack components, knee and elbow pads, eyewear, and helmets; and reusable cases and custom for applications in military ballistics panels, virtual training systems, drones, communications equipment, and rugged portable computers. In addition, the company provides engineered products and components to customers in the automotive, aerospace and defense, and industrial markets for applications in military uniform and gear components, automotive interior trim, air filtration, and protective cases and inserts. It markets and sells its products through a direct sales force. The company was founded in 1963 and is headquartered in Newburyport, Massachusetts.